WP5215 - Targeted agents in triple negative breast cancer - Homo sapiens
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ndexbio.org/viewer/networks/638dbceb-1439-11f0-9806-005056ae3c32
下载链接
链接失效反馈官方服务：
资源简介：
Schematic of the most relevant molecular pathways and targeted agents in tripe negative breast cancer (TNBC). Tyrosine kinase receptor is activated upon binding of growth factors leading to activation of signaling pathways. PI3K/AKT pathway and inhibitor drugs: Phosphorylated PI3K activate AKT. The activation of AKT triggers downstream protein complexes mTORC activation that initiate gene transcription and promote cell growth. AR pathway is activated in LAR subtype tumors. Platinum drugs act through DNA damaging mechanism. PARP inhibitors induce “synthetic lethality” in BRCA deficient tumors.
Pathway is based on figure figure in [Vagia et al](https://europepmc.org/article/MED/32276534).
创建时间：
2025-04-17
